Mark Verratti
Fortune : 4 M $ au 30/06/2026
Fortune : 4 M $ au 30/06/2026
Mark Steven Verratti is currently Managing Director at Myriad Genetics GmbH and Chief Operating Officer at Myriad Genetics, Inc. Former positions include Vice President-Sales at LivaNova USA, Inc. from 2005 to 2012, and SVP, Chief Sales & Business Development Officer at Assurex Health, Inc. Education includes undergraduate studies at The Pennsylvania State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MYRIAD GENETICS, INC. 0,67 % | 14/04/2026 | 629 646 ( 0,67 % ) | 4 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MYRIAD GENETICS, INC. | Directeur des opérations | 30/04/2025 |
Myriad Genetics GmbH
Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Develops therapeutic and predictive medicine products | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | President | - |
| CYBERONICS, INC. | Sales & Marketing | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
LivaNova USA, Inc.
LivaNova USA, Inc. Medical SpecialtiesHealth Technology Engages in design, development, sale and marketing of implantable medical devices | Health Technology |
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | Health Technology |
Myriad Genetics GmbH
Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national